SEC Form 4 · accession 0000899243-16-015983
Sorrento Therapeutics, Inc. · SRNE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeffrey Su
Officer — Executive VP and COO
Period of report
Mar 11, 2016
Accepted (ET)
Mar 15, 2016 · 4:16 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000850261
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionsF1 | $5.79 | Mar 11, 2016 | A | 40,000 | A | — | Mar 11, 2026 | Common Stock | 40,000 | 160,000 | D |
Explanation of responses
- F11/4 of the original number of shares subject to the option shall vest on March 11, 2017 and 1/48 of the original number of shares subject to the option shall vest following each one month period of service after March 11, 2017, subject to the reporting person's continued service to the Company through each such vesting date.